Randomized Phase II Study Evaluating Palbociclib in Addition to Letrozole as Neoadjuvant Therapy in Estrogen Receptor–Positive Early Breast Cancer: PALLET Trial

来曲唑 帕博西利布 医学 乳腺癌 雌激素受体 内科学 肿瘤科 泌尿科 癌症 转移性乳腺癌 三苯氧胺
作者
Stephen Johnston,Shannon Puhalla,Duncan Wheatley,Alistair Ring,Peter Barry,Chris Holcombe,Jean Francois Boileau,Louise Provencher,André Robidoux,Mothaffar F. Rimawi,Stuart McIntosh,I. Shalaby,Robert Stein,Michael P. Thirlwell,David Dolling,James P. Morden,Claire Snowdon,Sophie Perry,Chester Cornman,Leona Batten,Lisa K. Jeffs,Andrew Dodson,Vera Martins,Ankur Modi,C. Kent Osborne,Katherine L. Pogue‐Geile,Maggie C.U. Cheang,Norman Wolmark,Thomas B. Julian,Kate Fisher,Mairead MacKenzie,Maggie Wilcox,Cynthia Huang Bartlett,María Koehler,Mitch Dowsett,Judith M. Bliss,Samuel A. Jacobs
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:37 (3): 178-189 被引量:152
标识
DOI:10.1200/jco.18.01624
摘要

PURPOSE CDK4/6 inhibitors are used to treat estrogen receptor (ER)–positive metastatic breast cancer (BC) in combination with endocrine therapy. PALLET is a phase II randomized trial that evaluated the effects of combination palbociclib plus letrozole as neoadjuvant therapy. PATIENTS AND METHODS Postmenopausal women with ER-positive primary BC and tumors greater than or equal to 2.0 cm were randomly assigned 3:2:2:2 to letrozole (2.5 mg/d) for 14 weeks (A); letrozole for 2 weeks, then palbociclib plus letrozole to 14 weeks (B); palbociclib for 2 weeks, then palbociclib plus letrozole to 14 weeks (C); or palbociclib plus letrozole for 14 weeks. Palbociclib 125 mg/d was administered orally on a 21-days-on, 7-days-off schedule. Core-cut biopsies were taken at baseline and 2 and 14 weeks. Coprimary end points for letrozole versus palbociclib plus letrozole groups (A v B + C + D) were change in Ki-67 (protein encoded by the MKI67 gene; immunohistochemistry) between baseline and 14 weeks and clinical response (ordinal and ultrasound) after 14 weeks. Complete cell-cycle arrest was defined as Ki-67 less than or equal to 2.7%. Apoptosis was characterized by cleaved poly (ADP-ribose) polymerase. RESULTS Three hundred seven patients were recruited. Clinical response was not significantly different between palbociclib plus letrozole and letrozole groups ( P = .20; complete response + partial response, 54.3% v 49.5%), and progressive disease was 3.2% versus 5.4%, respectively. Median log-fold change in Ki-67 was greater with palbociclib plus letrozole compared with letrozole (−4.1 v −2.2; P < .001) in the 190 evaluable patients (61.9%), corresponding to a geometric mean change of −97.4% versus −88.5%. More patients on palbociclib plus letrozole achieved complete cell-cycle arrest (90% v 59%; P < .001). Median log-fold change (suppression) of cleaved poly (ADP-ribose) polymerase was greater with palbociclib plus letrozole versus letrozole (−0.80 v −0.42; P < .001). More patients had grade 3 or greater toxicity on palbociclib plus letrozole (49.8% v 17.0%; P < .001) mainly because of asymptomatic neutropenia. CONCLUSION Adding palbociclib to letrozole significantly enhanced the suppression of malignant cell proliferation (Ki-67) in primary ER-positive BC, but did not increase the clinical response rate over 14 weeks, which was possibly related to a concurrent reduction in apoptosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
派大星完成签到,获得积分10
刚刚
hhh发布了新的文献求助10
刚刚
1秒前
123完成签到,获得积分10
1秒前
wanci应助英勇的滑板采纳,获得10
1秒前
2秒前
xk完成签到,获得积分10
2秒前
微笑面包完成签到,获得积分10
2秒前
大白完成签到,获得积分10
3秒前
咕噜完成签到 ,获得积分10
3秒前
量子星尘发布了新的文献求助20
4秒前
Linlin关注了科研通微信公众号
4秒前
5秒前
5秒前
wgt发布了新的文献求助10
5秒前
lu发布了新的文献求助10
6秒前
Jasper应助尉迟希望采纳,获得10
6秒前
汉堡包应助YYYY采纳,获得10
6秒前
陶征应助温暖的颜演采纳,获得10
6秒前
6秒前
Gigi完成签到,获得积分10
7秒前
7秒前
whatever举报求助违规成功
7秒前
CAOHOU举报求助违规成功
7秒前
wy.he举报求助违规成功
7秒前
7秒前
张雷应助yuC采纳,获得10
7秒前
大个应助yuC采纳,获得30
7秒前
8秒前
8秒前
英姑应助Alina1874采纳,获得10
9秒前
二号完成签到,获得积分10
9秒前
英勇的滑板完成签到,获得积分10
10秒前
所所应助谨慎的哈密瓜采纳,获得50
10秒前
ppma发布了新的文献求助10
10秒前
11秒前
欧维发布了新的文献求助10
11秒前
12秒前
Rita完成签到,获得积分10
12秒前
学呀学完成签到 ,获得积分10
12秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 1000
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 310
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3979146
求助须知:如何正确求助?哪些是违规求助? 3523056
关于积分的说明 11215854
捐赠科研通 3260487
什么是DOI,文献DOI怎么找? 1800049
邀请新用户注册赠送积分活动 878813
科研通“疑难数据库(出版商)”最低求助积分说明 807092